Decreased ALKBH5, FTO, and YTHDF2 in Peripheral Blood Are as Risk Factors for Rheumatoid Arthritis

Table 2

Clinical details of the patients with RA and HC.

Clinical characteristic	RA	CON
Number of subjects	79	61
Sex, male/female	15/64	12/49
Age, years
Duration, day
DAS28-ESR
DAS28-CRP
SJC
TJC
VAS
RF, IU/ml
Anti-CCP, RU/ml
ESR, mm/h
CRP, mg/l
IgG, g/l
C3, g/l
C4, g/l
WBC, 10^9/l
RBC, 10^12/l
HGB, g/l
HCT, l/l
PLT, 10^9/l
L, 10^9/l
L, %
M, 10^9/l
M, %
N, 10^9/l
N, %
PLR
NLR
LMR

RA compared to CON. Anti-cyclic citrullinated peptide antibodies (Anti-CCP), health control (CON), C-reactive protein (CRP), disease activity score (DAS28), erythrocyte sedimentation rate (ESR), hematocrit (HCT), hemoglobin (HGB), lymphocyte count (L), lymphocyte percentage (L%), lymphocyte-to-monocyte ratio (LMR), monocyte count (M), monocyte percentage (M%), neutrophils count (N), neutrophils percentage (N%), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), platelet count (PLT), tender joint count (TJC), rheumatoid arthritis (RA), red blood cell count (RBC), rheumatoid factors (RF), swollen joint count (SJC), Visual Analogue Scale (VAS), and white blood cell count (WBC).